A real-time dashboard of clinical trials for COVID-19

The Lancet Digital Health

Volumn 2, Issue 6, 2020, Pages e286-e287

  Thorlund, Kristian ^a   Dron, Louis ^a   Park, Jay ^b   Hsu, Grace ^a   Forrest, Jamie I ^b   Mills, Edward J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARBIDOL; AZITHROMYCIN; FAVIPIRAVIR; HYDROXYCHLOROQUINE; LOPINAVIR PLUS RITONAVIR; REMDESIVIR; SARILUMAB; TOCILIZUMAB;

ARTIFICIAL INTELLIGENCE; CHINESE MEDICINE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CONVALESCENT PLASMA THERAPY; CORONAVIRUS DISEASE 2019; DRUG EFFICACY; HUMAN; INFORMATION PROCESSING; LETTER; PLASMA TRANSFUSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; STEM CELL TRANSPLANTATION;

EID: 85085336361     PISSN: None     EISSN: 25897500     Source Type: Journal    
DOI: 10.1016/S2589-7500(20)30086-8     Document Type: Letter

References (5)

1. Cao, B, Wang, Y, Wen, D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med, 2020 published online March 18. DOI:10.1056/NEJMoa2001282.
2. Chen, J, Liu, L, Liu, P, et al. A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19). J Zhejiang Univ (Med Sci), 2020 published onlne March 6. DOI:10.3785/j.issn.1008-9292.2020.03.03.
3. Chen, C, Huang, J, Yin, P, et al. Favipiravir versus arbidol for COVID-19: a randomized clinical trial. medRxiv, 2020 published onine April 8. DOI: 10.1101/2020.03.17.20037432 (preprint).
4. Yao, X, Ye, F, Zhang, M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis, 2020 published online March 9. DOI: 10.1093/cid/ciaa237.
5. Gautret, P, Lagier, JC, Parola, P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents, 2020 published online March 20. DOI:10.1016/j.ijantimicag.2020.105949.